A risk of COVID-19 infection for cancer patients is reported slightly high compared with general citizens. Among patients with cancer and COVID-19, severe illness and mortality is slightly high and associated with general risk factors and risk factors unique to patients with cancer. Cancer therapy should not be stopped or postponed under COVID-19 because cancer will be fatal disease if delaying or stopping cancer treatment. Clinical guidelines for cancer chemotherapy is discussed under COVID-19 in this article.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
cancer
8
guidelines cancer
8
cancer chemotherapy
8
patients cancer
8
risk factors
8
covid-19
5
[clinical guidelines
4
chemotherapy covid-19
4
covid-19 world]
4
world] risk
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!